Skip to main content
Erschienen in: Knee Surgery, Sports Traumatology, Arthroscopy 7/2017

Open Access 08.04.2017 | Elbow

Donor-site morbidity after osteochondral autologous transplantation for osteochondritis dissecans of the capitellum: a systematic review and meta-analysis

verfasst von: Rens Bexkens, Paul T. Ogink, Job N. Doornberg, Gino M. M. J. Kerkhoffs, Denise Eygendaal, Luke S. Oh, Michel P. J. van den Bekerom

Erschienen in: Knee Surgery, Sports Traumatology, Arthroscopy | Ausgabe 7/2017

Abstract

Purpose

To determine the rate of donor-site morbidity after osteochondral autologous transplantation (OATS) for capitellar osteochondritis dissecans.

Methods

A literature search was performed in PubMed/MEDLINE, Embase, and Cochrane Library to identify studies up to November 6, 2016. Criteria for inclusion were OATS for capitellar osteochondritis dissecans, reported outcomes related to donor sites, ≥10 patients, ≥1 year follow-up, and written in English. Donor-site morbidity was defined as persistent symptoms (≥1 year) or cases that required subsequent intervention. Patient and harvest characteristics were described, as well as the rate of donor-site morbidity. A random effects model was used to calculate and compare weighted group proportions.

Results

Eleven studies including 190 patients were included. In eight studies, grafts were harvested from the femoral condyle, in three studies, from either the 5th or 6th costal-osteochondral junction. The average number of grafts was 2 (1–5); graft diameter ranged from 2.6 to 11 mm. In the knee-to-elbow group, donor-site morbidity was reported in 10 of 128 patients (7.8%), knee pain during activity (7.0%) and locking sensations (0.8%). In the rib-to-elbow group, one of 62 cases (1.6%) was complicated, a pneumothorax. The proportion in the knee-to-elbow group was 0.04 (95% CI 0.0–0.15), and the proportion in the rib-to-elbow group was 0.01 (95% CI 0.00–0.06). There were no significant differences between both harvest techniques (n.s.).

Conclusions

Donor-site morbidity after OATS for capitellar osteochondritis dissecans was reported in a considerable group of patients.

Level of evidence

Level IV, systematic review of level IV studies.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1007/​s00167-017-4516-8) contains supplementary material, which is available to authorized users.

Introduction

Osteochondritis dissecans (OCD) of the capitellum is a disorder of the subchondral bone and articular cartilage [3, 23, 32]. This condition is primarily seen in teenagers engaged in sporting activities in which the elbow is repetitively exposed to extensive valgus forces, such as baseball and gymnastics [3, 23, 32]. In early phases, a stable capitellar OCD may cause pain and effusion, while in advanced stages, the OCD may become unstable and cause locking, restricted range of motion, and instability [3, 23, 32]. Stable OCD may initially be treated nonoperatively with activity modification and physical therapy [17, 18], whereas unstable lesions require operative treatment. Several surgical options have been developed over the past two decades including arthroscopic debridement with or without marrow stimulation [13, 26, 29], fragment fixation [7, 10, 31], and osteochondral autologous transplantation (OATS) [15, 16, 24, 33].
OATS has become a popular treatment option for large, unstable lesions (diameter > 10 mm) with lateral wall involvement, as well as also for athletes without an acceptable outcome after less invasive techniques [8, 15, 22, 24]. In OATS, a single or multiple osteochondral grafts are harvested from either the less-weight-bearing parts of the femoral condyle [8, 11, 15, 24] or the costal-osteochondral junction [22, 30]. The cylindrical donor plug consisting of hyaline cartilage and subchondral bone is then transplanted into the defect area to restore the integrity of the articular surface of the capitellum. A major disadvantage of this procedure is the need to harvest one or multiple grafts from an asymptomatic knee or the rib area in an adolescent athlete and thus the risk for morbidity at the donor site [2, 12, 27]. Recently, a review conducted by Andrade et al. reported knee donor-site morbidity rates of 17% and 6% for ankle and knee mosaicplasty procedures, respectively [2]. In contrast, two studies involving adolescent athletes who underwent OATS for OCD of the capitellum found no adverse effects related to the donor site [9, 35]. Interestingly, Weigelt et al. reported substantial donor-site morbidity in eight of 14 patients treated for capitellar OCD [33]. The vast majority of patients with capitellar OCD are high-demand athletes who are younger than patients with knee and ankle OCD [2, 9]. Also, as opposed to knee and ankle OCD, grafts have been harvested from both the femoral condyle and costal-osteochondral junction in the treatment of capitellar OCD [9, 30]. Knowing the overall risk for donor-site morbidity following capitellar OATS is relevant in surgical decision making, as well as it is essential to be able to counsel patients about the risk for possible donor-site effects. To our knowledge, the risk of donor-site morbidity after OATS in this particular population is still unknown.
The purpose of this study was to determine the rate of donor-site morbidity following osteochondral autologous transplantation for capitellar osteochondritis dissecans. The hypothesis op the study was that there would be no difference in the proportion of donor-site morbidity between graft harvesting from the femoral condyle or costal-osteochondral junction.

Materials and methods

Protocol

The findings of this systematic review were reported according to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines [14].

Selection criteria

Studies that met the following inclusion criteria were included: (1) osteochondral autologous transplantation for capitellar OCD, (2) reported outcomes related to the donor site, (3) minimum inclusion of 10 patients, (4) minimum follow-up of one year, and (5) written in English. Case reports, reviews, and cadaveric studies were excluded. Donor-site morbidity was defined as the presence of persistent symptoms (≥1 year) after graft harvesting, as well as the need for subsequent intervention to treat complications related to the donor site.

Search strategy

A literature search was performed in the following databases up to November 6, 2016: PubMed/MEDLINE, Embase, and the Cochrane Library. The PubMed/MEDLINE search strategy was adjusted into similar search strategies for other databases (Online Appendix 1). Reference lists of retrieved studies were manually searched for additional studies potentially meeting the inclusion criteria.

Study selection

Study selection was independently performed by two authors. First, title and abstract were screened to identify potentially relevant papers (R.B. and P.O.). These results were verified by two senior authors (L.O. and M.v.d.B.). Subsequently, manuscripts were retrieved when title or abstract revealed insufficient information to determine the appropriateness for inclusion. Disagreement was resolved by discussion or with arbitration when necessary by the senior authors (L.O. and M.v.d.B.) when differences remained.

Data extraction

The main outcome of interest was the presence or absence of donor-site morbidity (persistent symptoms or need for subsequent intervention) after capitellar OATS. The following data were extracted from each study: author names, year of publication, patient demographics, follow-up time, harvest method, graft characteristics, and the use of fillers. The following outcomes related to the donor site were extracted: symptoms (e.g., pain, locking, and instability), physical examination (e.g., effusion and range of motion), complications (e.g., infection, nerve injury, or subsequent treatment), patient reported outcome scores, imaging evaluation [e.g., radiographs, computed tomography, or magnetic resonance imaging (MRI)], and anatomic and histological outcomes. Data extraction was independently performed by two authors (R.B. and P.O.) and verified by two senior authors (L.O. and M.v.d.B.). Articles were not blinded for author, affiliation, and source.

Methodological quality assessment

Two authors (R.B. and P.O.) independently judged the methodological quality of included studies using the checklist for quality appraisal of case series studies that was developed at the Institute of Health Economics (IHE) [5, 20]. Each of the 20 criteria of the checklist were answered with either ‘yes,’ ‘no,’ or ‘partial’ or ‘unclear.’ For estimating the risk of bias for each study, ‘partial’ responses were considered ‘yes,’ and ‘unclear’ responses were considered ‘no.’ A study with 0–2 ‘no’ responses was considered to have a low risk of bias, 3–5 ‘no’ responses a moderate risk, 6–8 ‘no’ responses a high risk, and 9 or more ‘no’ responses a very high risk of bias. In case of disagreement, two senior authors (L.O. and M.v.d.B.) were involved to solve the differences.

Statistical analysis

Categorical data were displayed as absolute numbers with frequencies; continuous data were displayed as means with sample range.
The main outcomes of interest were the rate of donor-site morbidity within the knee-to-elbow group and rib-to-elbow group. Proportions of donor-site morbidity were calculated for each study using the Freeman-Tukey double arcsine transformation. Subsequently, a random effects model, to account for heterogeneity across studies, was used to calculate weighted group proportions for each harvest technique, and to compare proportions between the two techniques [19, 34]. A p value <0.05 was considered significant. Statistical analyses were performed with the use of Stata 13.0 (College Station, TX, USA).

Results

Population and harvest characteristics

A detailed summary of patient and harvest characteristics for each study is given in Table 1. A total of 11 studies including 190 patients met the criteria after careful systematic selection (Fig. 1) [9, 11, 15, 16, 21, 22, 24, 28, 30, 33, 35]. The mean age across the selected studies was 15 years (range, 14–18), and the mean follow-up length was 37 months (range, 22–84).
Table 1
Patient and harvest characteristics
Author
Year
No. of patients
Age, years
Follow-up, months
Harvest method
Donor site
Side
No. of grafts
Graft diameter, mm
Graft depth, mm
Use of fillers
Knee-to-elbow osteochondral autologous transplantation (N = 128)
 Yamamoto
2006
18
14
42
Arthroscopy
Lateral intercondylar notch or lateral side of the PF joint
1–3
5–9
10
No
 Iwasaki
2007
11
14
26
Arthrotomy
Superolateral FC
Contralateral
3.4 (2–5)
2.6–6.0
10–15
Bone wax
 Ovesen
2011
10
18
30
Arthrotomy
Superolateral FC
Ipsilateral
No
 Nishimura
2011
12
14
34
Superolateral FC
Contralateral
2.1 (1–3)
6–8
Bone graft from capitellum
 Kosaka
2013
19
14
59
None-weight bearing areas FC
No
 Maruyama
2014
33
14
28
Arthrotomy
Superolateral FC
Ipsilateral
1.8 (1–3)
7 (5–9)
14 (9–20)
No
Weigelt
2015
14
18
84
Arthrotomy
Superolateral FC
Ipsilateral
1
8–11
No
 Lyons
2015
11
15
23
Arthrotomy
Lateral trochlear ridge FC
Ipsilateral
Tru-Fit plug if diameter > 10 mm or 2 × 8 mm
Rib-to-elbow Osteochondral Autologous Transplantation (N = 62)
 Sato
2008
14
16
22
Open
5th/6th costal-osteochondral junction
Ipsilateral
1–2
No
 Shimada
2012
26
16
36
Open
5th/6th costal-osteochondral junction
Ipsilateral
1–1.5
18
No
 Nishinaka
2014
22
14
27
Open
6th costal-osteochondral junction
‘Right side’
20
No
PF patellofemoral, FC femoral condyle
The knee served as the donor site in 128 patients across eight studies (Table 1) [9, 11, 15, 16, 21, 24, 33, 35]. The average number of grafts harvested was 2 (range 1–5) [9, 16, 21, 33, 35], and graft diameter ranged from 2.6 to 11 mm [9, 16, 21, 33, 35]. In 62 patients across three studies, either the 5th or 6th costal-osteochondral junction served as the harvest site [22, 28, 30]. Either one or two grafts were harvested for each patient [22, 28, 30].

Donor-site morbidity

A detailed summary of donor-site effects per study is given in Table 2. In the knee-to-elbow group, donor-site morbidity after capitellar OATS was reported in 10 of 128 patients, resulting in a donor-site morbidity rate of 7.8%. Knee pain while stair climbing and heavy lifting were reported in nine patients (7.0%) and locking sensations in one patient (0.8%) (Table 2) [9, 16, 33]. In the rib-to-elbow group, donor-site morbidity was reported in one of 62 patients, resulting in a donor-site morbidity rate of 1.6%. One case was complicated by a pneumothorax due to damage to the costal pleura, which required insertion of a chest tube [30].
Table 2
Donor-site effects after osteochondral autologous transplantation for capitellar osteochondritis dissecans
Author
Complications
Physical examination
Patient reported outcomes
Imaging
Knee-to-elbow osteochondral autologous transplantation (N = 128)
 Yamamoto
No
No effusion
No pain
 Iwasaki
No
Effusion up to 5 weeks in 8 pts (mean: 3 weeks); full range of motion; thigh and calf girth 100%
Lysholm 99.6 (range 96–100), IKDC normal, 1 pt had knee pain with stair climbing at final follow-up
MRI: 50–100% defect fill in 6 pts (67%), normal signals in 4 pts at donor sites (44%), effusion in 1 pt, no subchondral edema or hypertrophic changes at donor site
 Ovesen
No
No pain
 Nishimura
No
No effusion at 3 months; 80% muscle strength at 6 months, 11 pts regained strength at 1 year
Lysholm 100 at 6 months; Visual Analog Scale 0 at 3 months; 100% return to sports without any donor knee disturbances
Radiographs: absence of osteoarthritis at 2 years
 Kosaka
No
‘None of the donor knees which were removed of osteocartilaginous tissues experienced negative effects’
 Maruyama
No
Full range of motion
Lysholm 99.8; 1 pt had mild anterior knee pain during exercise
 Weigelt
No
Lysholm 90.9; 7 patients occasional pain during lifting, 1 locking sensations
 Lyons
No
‘No complaints regarding the donor knee at final follow-up’
Rib-to-elbow osteochondral autologous transplantation (N = 62)
 Sato
No
2–3 days pain postoperatively; no complaints during athletic activities
 Shimada
Pneumothorax, resolved after tube insertion
Hard scar tissue
Few days pain postoperatively
Radiographs: subperiostal bone formation in some pts
 Nishinaka
No
No pain or symptoms
IKDC International Knee Documentation Committee, MRI magnetic resonance imaging, pt patient
The proportion of donor-site morbidity in the knee-to-elbow group was 0.04 (95% CI 0.0–0.15), and the proportion in the rib-to-elbow group was 0.01 (95% CI 0.00–0.06) (Fig. 2). There was no significant difference between the two harvest techniques in terms of proportion of donor-site morbidity (p > 0.05).

Methodological quality

The results of methodological quality assessment of individual studies using the IHE scale are presented in Table 3. According to the criteria of the IHE checklist for critical appraisal of case series studies, the estimated potential risk of bias was low for one study [21], moderate for nine studies [9, 11, 15, 16, 22, 24, 30, 33, 35], and high for one study [28]. Solely ‘no’ responses were awarded to question 3 and 11, which are related to the patient recruitment process and blinding of outcome assessors, respectively. Here, no study recruited patients from multiple centers, nor was outcome assessment blinded. Three more questions, also related to outcome measures (10, measures established a priori; 12, appropriateness of measures; 13, before and after intervention measured), were awarded with ‘no’ or ‘partial’ responses in more than half of the included studies. By contrast, most criteria with regard to the study aim (question 1), study population (question 5–7), intervention (question 8), statistical analysis (question 14), results/conclusions (question 15–19), and sources of support (question 20) were awarded a ‘yes’ response.
Table 3
Quality assessment of case series studies using the quality appraisal checklist of the institute of health economics (IHE)
 
Yamamoto
Iwasaki
Ovesen
Nishimura
Kosaka
Maruyama
Weigelt
Lyons
Sato
Shimada
Nishinaka
1. Was the hypothesis/aim/objective of the study clearly stated?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
2. Was the study conducted prospectively?
Unclear
No
Unclear
Yes
No
Unclear
No
No
Unclear
No
Unclear
3. Were the cases collected in more than one centre?
No
No
No
No
No
No
No
No
No
No
No
4. Were patients recruited consecutively?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
5. Were the characteristics of the patients included in the study described?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
6. Were the eligibility criteria (inclusion and exclusion criteria) for entry into the study clearly stated?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
7. Did patients enter the study at a similar point in the disease?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
8. Was the intervention of interest clearly described?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
9. Were additional interventions (co-interventions) clearly described?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
10. Were relevant outcome measures established a priori?
Partial
Yes
Partial
Yes
Yes
Yes
Yes
Partial
Partial
Partial
Partial
11. Were outcome assessors blinded to the intervention that patients received?
No
No
No
No
No
No
No
No
No
No
No
12. Were the relevant outcomes measured using appropriate objective/subjective methods?
Partial
Yes
Partial
Yes
Partial
Yes
Partial
Partial
Partial
Yes
Partial
13. Were the relevant outcome measures made before and after the intervention?
No
Partial
No
Partial
No
Partial
No
No
No
No
No
14. Were the statistical tests used to assess the relevant outcomes appropriate?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
15. Was follow-up long enough for important events and outcomes to occur?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
16. Were losses to follow-up reported?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
17. Did the study provided estimates of random variability in the data analysis of relevant outcomes?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
18. Were the adverse events reported?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
19. Were the conclusions of the study supported by results?
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
20. Were both competing interests and sources of support for the study reported?
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
No
Yes
Yes
Overall risk of bias
Moderate
Moderate
Moderate
Low
Moderate
Moderate
Moderate
Moderate
High
Moderate
Moderate

Discussion

The most important finding of the present study is that donor-site morbidity after osteochondral autologous transplantation for capitellar osteochondritis dissecans occurred in 7.8% within the knee-to-elbow group and 1.6% within the rib-to-elbow group. In the knee-to-elbow group, knee pain during daily activities (7.0%) and locking sensations (0.8%) were reported; in the rib-to-elbow group, one case was complicated by a pneumothorax. There was no significant difference in proportion of donor-site morbidity between the two harvest techniques. The findings of this systematic review emphasize the importance of associated donor-site morbidity following graft harvesting in the treatment of capitellar OCD.
The rate of donor-site morbidity in our study is comparable to the morbidity rate after knee-to-knee OATS (6%), as reported by Andrade et al. [2]. Interestingly, the authors reported a higher rate after knee-to-ankle OATS (17%) [32]. The higher rate compared to our findings may be the result of more grafts that were harvested (three versus two) [2], although the influence of the number of grafts on morbidity is controversial [1, 2, 25, 27]. Patient characteristics may have played a role as well. The vast majority of patients in our study were adolescent (15 years), high-demanding athletes, while patients with talar OCD are typically older (32 years [25]). We hypothesized that patients in our study may have been in a better physical condition before treatment, and therefore faster recovery with less donor-site effects may be expected.
In the present study, the rate of donor-site morbidity ranged from 0 to 57% in studies in whom grafts were harvested from the knee. Weigelt et al. reported morbidity in eight of 14 patients (57%): occasional pain during heavy lifting in seven patients and intermittent locking sensations in one patient [33]. The advanced age after a relative long follow-up (7 years) may be the reason for more morbidity, as well as it may be the result of large grafts (8–11 mm) that were harvested [1, 2, 25, 27]. Two included studies focused on donor-site effects in particular [9, 21]. Despite encouraging clinical results reported by Iwasaki et al., MRI evaluation revealed alterations in signal intensity in 89% of donor sites, suggesting fibrous filling of donor holes [9]. Long-term follow-up is needed to see if these changes in signal intensity are permanent and clinically meaningful. Nishimura et al. found a delay in recovery of quadriceps muscle strength [21]. This indicates that even if symptoms may resolve quickly after harvesting, the donor knee is at risk for injury due to muscle weakness within the first year. Three studies attempted to prevent postoperative bleeding by filling donor tunnels [9, 15, 21]. As included studies were limited by small case series, potential beneficial effects remain unclear. Favorable results have been reported using synthetic implants in repair of knee OCD [4, 6], although literature lacks large sample comparison studies.
Three studies that were included in this review harvested grafts from either the 5th or 6th costal-osteochondral junction to repair capitellar OCD [22, 28, 30]. Although hard scar tissue was detected in palpation, radiographs showed new subperiostal bone formation and no long-term symptoms were observed [30]. However, harvesting grafts from the rib area is a technically demanding procedure that has been described by only a few studies. Most surgeons who perform capitellar OATS are more familiar with knee anatomy rather than rib anatomy. Moreover, risk for devastating donor-site morbidity remains as harvesting may be complicated by a pneumothorax due to close proximity to the costal pleura, which may lead to a prolonged hospital stay [30]. If familiar with this technique, this may be an option in the treatment of large capitellar OCDs (>15 mm). As large lesions usually require multiple cylindrical grafts, one may want to avoid the risk for donor-site morbidity of the knee.
Using the IHE scale to evaluate the methodological quality of included studies [5, 20], the estimated potential risk of bias ranged from low to high, with the majority of studies found to be of moderate risk of bias (9 of 11). Studies scored the lowest on criteria related to outcome measures, as well as on the fact that cases were collected in a single center in each study. Therefore, the findings of this systematic review should be interpreted by taking into account some limitations. First, a major limitation is the incomplete reporting regarding outcomes related to the donor site. As physical examination or imaging was rarely thoroughly reported, studies lack objective assessment of donor-site effects. Additionally, subjective assessment of knee function by means of patient reported outcome measures was only performed in four of eight studies (Lysholm score) [9, 16, 21, 33]. In the remaining studies, no attempt was made to evaluate knee function, nor was physical examination thoroughly described [11, 15, 24, 35], as this was also the case in two rib-to-elbow studies [22, 28]. Also, in none of the included studies, either subjective or objective preoperative assessment of the donor site was reported. As data were obtained from studies that evaluated donor-site effects in varying degrees, we hypothesized that donor-site morbidity may be substantially underreported in this population. Also, due to incomplete reporting, we were unable to investigate associations between morbidity and harvest characteristics including donor-site location and the size or number of grafts. Second, included studies are limited by case series with small numbers of patients because capitellar OCD is a rare condition in the general population, and capitellar OATS is a relatively new procedure. Third, after pooling the data of included studies, we found no significant difference between the proportions of donor-site morbidity for the knee-to-elbow group and the rib-to-elbow group (p > 0.05). One may argue whether it is valid to combine study data because of between-study variance; however, we attempted to alleviate statistical heterogeneity with the use of a random effects model. This model has been used previously in systematic reviews who pooled data from case series studies [19, 34].
Future studies should comprehensively evaluate effects related to the donor site. Patient’s symptoms and physical examination should be reported for each patient. Additionally, the use of a patient reported outcome measure to assess knee function should be a routine part of clinical evaluation, both preoperatively and postoperatively. Radiographs should be performed to evaluate potential progression to osteoarthritis at 1 year and may be performed in cases in which donor fillers were used. MRI evaluation should, because of cost-effectiveness reasons, only be ordered in case of persistent symptoms. Besides the evaluation of donor-site effects, harvest characteristics should be reported in great detail, such as donor location, number of grafts, graft diameter, and depth. Also, alternative harvest methods should be investigated to have no longer the need to violate the integrity of an asymptomatic knee or rib in an adolescent athlete.
The findings of the present investigation demonstrate a considerable risk for donor-site morbidity following capitellar OATS. Although good-to-excellent results related to the elbow have been reported after capitellar OATS, surgeons should be aware of the risk for donor-site morbidity and patients should be counseled about this issue. Knowing the overall risk for donor-site morbidity is also relevant in surgical decision making. Taking this into consideration, surgeons could consider other resurfacing techniques such as allografting or autologous chondrocyte transplantation.

Conclusions

Osteochondral autologous transplantation in the treatment of capitellar osteochondritis dissecans may lead to donor-site morbidity in a considerable group of patients, either after harvesting from the femoral condyle (7.8%) or costal-osteochondral junction (1.6%).

Acknowledgements

The authors would like to thank Roos Steenhuis, medical librarian of the Onze Lieve Vrouwe Gasthuis, for the assistance in performing the literature search.

Compliance with ethical standards

Conflict of interest

R. Bexkens, P.T. Ogink, J.N. Doornberg, G.M.M.J. Kerkhoffs, D. Eygendaal, L.S. Oh, and M.P.J. van den Bekerom declare that they have no conflict of interest.

Funding

There was no outside funding or grants received that assisted in this study.

IRB/medical ethics committee

Review was not needed for this study since it is a systematic review.

Disclaimers

None.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Orthopädie & Unfallchirurgie

Kombi-Abonnement

Mit e.Med Orthopädie & Unfallchirurgie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Al-Shaikh RA, Chou LB, Mann JA, Dreeben SM, Prieskorn D (2002) Autologous osteochondral grafting for talar cartilage defects. Foot Ankle Int 23:381–389CrossRefPubMed Al-Shaikh RA, Chou LB, Mann JA, Dreeben SM, Prieskorn D (2002) Autologous osteochondral grafting for talar cartilage defects. Foot Ankle Int 23:381–389CrossRefPubMed
2.
Zurück zum Zitat Andrade R, Vasta S, Pereira R, Pereira H, Papalia R, Karahan M, Oliveira JM, Reis RL, Espregueira-Mendes J (2016) Knee donor-site morbidity after mosaicplasty - a systematic review. J Exp Orthop 3:31CrossRefPubMedPubMedCentral Andrade R, Vasta S, Pereira R, Pereira H, Papalia R, Karahan M, Oliveira JM, Reis RL, Espregueira-Mendes J (2016) Knee donor-site morbidity after mosaicplasty - a systematic review. J Exp Orthop 3:31CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Baker CL 3rd, Romeo AA, Baker CL Jr (2010) Osteochondritis dissecans of the capitellum. Am J Sports Med 38:1917–1928CrossRefPubMed Baker CL 3rd, Romeo AA, Baker CL Jr (2010) Osteochondritis dissecans of the capitellum. Am J Sports Med 38:1917–1928CrossRefPubMed
4.
Zurück zum Zitat Feczko P, Hangody L, Varga J, Bartha L, Dioszegi Z, Bodo G, Kendik Z, Modis L (2003) Experimental results of donor site filling for autologous osteochondral mosaicplasty. Arthroscopy 19:755–761CrossRefPubMed Feczko P, Hangody L, Varga J, Bartha L, Dioszegi Z, Bodo G, Kendik Z, Modis L (2003) Experimental results of donor site filling for autologous osteochondral mosaicplasty. Arthroscopy 19:755–761CrossRefPubMed
5.
Zurück zum Zitat Guo B, Moga C, Harstall C, Schopflocher D (2016) A principal component analysis is conducted for a case series quality appraisal checklist. J Clin Epidemiol 69:199–207. e192 Guo B, Moga C, Harstall C, Schopflocher D (2016) A principal component analysis is conducted for a case series quality appraisal checklist. J Clin Epidemiol 69:199–207. e192
6.
Zurück zum Zitat Hangody L, Bartha L, Hamann D, Pieper J, Peters F, Riesle J, Vajda A, Novak PK, Hangody LR, Vasarhelyi G, Bodo L, Van Blitterswijk C, De Wijn J, Kenyeres A, Modis L, Balo E (2013) A clinical feasibility study to evaluate the safety and efficacy of PEOT/PBT implants for human donor site filling during mosaicplasty. Eur J Orthop Surg Traumatol 23:81–91CrossRefPubMed Hangody L, Bartha L, Hamann D, Pieper J, Peters F, Riesle J, Vajda A, Novak PK, Hangody LR, Vasarhelyi G, Bodo L, Van Blitterswijk C, De Wijn J, Kenyeres A, Modis L, Balo E (2013) A clinical feasibility study to evaluate the safety and efficacy of PEOT/PBT implants for human donor site filling during mosaicplasty. Eur J Orthop Surg Traumatol 23:81–91CrossRefPubMed
7.
Zurück zum Zitat Harada M, Ogino T, Takahara M, Ishigaki D, Kashiwa H, Kanauchi Y (2002) Fragment fixation with a bone graft and dynamic staples for osteochondritis dissecans of the humeral capitellum. J Shoulder Elb Surg 11:368–372CrossRef Harada M, Ogino T, Takahara M, Ishigaki D, Kashiwa H, Kanauchi Y (2002) Fragment fixation with a bone graft and dynamic staples for osteochondritis dissecans of the humeral capitellum. J Shoulder Elb Surg 11:368–372CrossRef
8.
Zurück zum Zitat Iwasaki N, Kato H, Ishikawa J, Masuko T, Funakoshi T, Minami A (2009) Autologous osteochondral mosaicplasty for osteochondritis dissecans of the elbow in teenage athletes. J Bone Joint Surg Am 91:2359–2366CrossRefPubMed Iwasaki N, Kato H, Ishikawa J, Masuko T, Funakoshi T, Minami A (2009) Autologous osteochondral mosaicplasty for osteochondritis dissecans of the elbow in teenage athletes. J Bone Joint Surg Am 91:2359–2366CrossRefPubMed
9.
Zurück zum Zitat Iwasaki N, Kato H, Kamishima T, Suenaga N, Minami A (2007) Donor site evaluation after autologous osteochondral mosaicplasty for cartilaginous lesions of the elbow joint. Am J Sports Med 35:2096–2100CrossRefPubMed Iwasaki N, Kato H, Kamishima T, Suenaga N, Minami A (2007) Donor site evaluation after autologous osteochondral mosaicplasty for cartilaginous lesions of the elbow joint. Am J Sports Med 35:2096–2100CrossRefPubMed
10.
Zurück zum Zitat Koehler SM, Walsh A, Lovy AJ, Pruzansky JS, Shukla DR, Hausman MR (2015) Outcomes of arthroscopic treatment of osteochondritis dissecans of the capitellum and description of the technique. J Shoulder Elbow Surg 24:1607–1612CrossRefPubMed Koehler SM, Walsh A, Lovy AJ, Pruzansky JS, Shukla DR, Hausman MR (2015) Outcomes of arthroscopic treatment of osteochondritis dissecans of the capitellum and description of the technique. J Shoulder Elbow Surg 24:1607–1612CrossRefPubMed
11.
Zurück zum Zitat Kosaka M, Nakase J, Takahashi R, Toratani T, Ohashi Y, Kitaoka K, Tsuchiya H (2013) Outcomes and failure factors in surgical treatment for osteochondritis dissecans of the capitellum. J Pediatr Orthop 33:719–724CrossRefPubMed Kosaka M, Nakase J, Takahashi R, Toratani T, Ohashi Y, Kitaoka K, Tsuchiya H (2013) Outcomes and failure factors in surgical treatment for osteochondritis dissecans of the capitellum. J Pediatr Orthop 33:719–724CrossRefPubMed
12.
Zurück zum Zitat LaPrade RF, Botker JC (2004) Donor-site morbidity after osteochondral autograft transfer procedures. Arthroscopy 20:e69–e73CrossRefPubMed LaPrade RF, Botker JC (2004) Donor-site morbidity after osteochondral autograft transfer procedures. Arthroscopy 20:e69–e73CrossRefPubMed
13.
Zurück zum Zitat Lewine EB, Miller PE, Micheli LJ, Waters PM, Bae DS (2015) Early Results of Drilling and/or Microfracture for Grade IV Osteochondritis Dissecans of the Capitellum. J Pediatr Orthop 36:803–809CrossRef Lewine EB, Miller PE, Micheli LJ, Waters PM, Bae DS (2015) Early Results of Drilling and/or Microfracture for Grade IV Osteochondritis Dissecans of the Capitellum. J Pediatr Orthop 36:803–809CrossRef
14.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W65–W94CrossRefPubMed Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W65–W94CrossRefPubMed
15.
Zurück zum Zitat Lyons ML, Werner BC, Gluck JS, Freilich AM, Dacus AR, Diduch DR, Chhabra AB (2015) Osteochondral autograft plug transfer for treatment of osteochondritis dissecans of the capitellum in adolescent athletes. J Shoulder Elb Surg 24:1098–1105CrossRef Lyons ML, Werner BC, Gluck JS, Freilich AM, Dacus AR, Diduch DR, Chhabra AB (2015) Osteochondral autograft plug transfer for treatment of osteochondritis dissecans of the capitellum in adolescent athletes. J Shoulder Elb Surg 24:1098–1105CrossRef
16.
Zurück zum Zitat Maruyama M, Takahara M, Harada M, Satake H, Takagi M (2014) Outcomes of an open autologous osteochondral plug graft for capitellar osteochondritis dissecans: time to return to sports. Am J Sports Med 42:2122–2127CrossRefPubMed Maruyama M, Takahara M, Harada M, Satake H, Takagi M (2014) Outcomes of an open autologous osteochondral plug graft for capitellar osteochondritis dissecans: time to return to sports. Am J Sports Med 42:2122–2127CrossRefPubMed
17.
Zurück zum Zitat Matsuura T, Kashiwaguchi S, Iwase T, Takeda Y, Yasui N (2008) Conservative treatment for osteochondrosis of the humeral capitellum. Am J Sports Med 36:868–872CrossRefPubMed Matsuura T, Kashiwaguchi S, Iwase T, Takeda Y, Yasui N (2008) Conservative treatment for osteochondrosis of the humeral capitellum. Am J Sports Med 36:868–872CrossRefPubMed
18.
Zurück zum Zitat Mihara K, Tsutsui H, Nishinaka N, Yamaguchi K (2009) Nonoperative treatment for osteochondritis dissecans of the capitellum. Am J Sports Med 37:298–304CrossRefPubMed Mihara K, Tsutsui H, Nishinaka N, Yamaguchi K (2009) Nonoperative treatment for osteochondritis dissecans of the capitellum. Am J Sports Med 37:298–304CrossRefPubMed
19.
Zurück zum Zitat Miller JJ (1978) The inverse of the Freeman–Tukey double arcsine transformation. Am Stat 32:138–138 Miller JJ (1978) The inverse of the Freeman–Tukey double arcsine transformation. Am Stat 32:138–138
20.
Zurück zum Zitat Moga C, Guo B, Schopflocher D, Harstall C (2012) Development of a quality appraisal tool for case series studies using a modified Delphi technique. Institute of Health Economics, Edmonton AB Moga C, Guo B, Schopflocher D, Harstall C (2012) Development of a quality appraisal tool for case series studies using a modified Delphi technique. Institute of Health Economics, Edmonton AB
21.
Zurück zum Zitat Nishimura A, Morita A, Fukuda A, Kato K, Sudo A (2011) Functional recovery of the donor knee after autologous osteochondral transplantation for capitellar osteochondritis dissecans. Am J Sports Med 39:838–842CrossRefPubMed Nishimura A, Morita A, Fukuda A, Kato K, Sudo A (2011) Functional recovery of the donor knee after autologous osteochondral transplantation for capitellar osteochondritis dissecans. Am J Sports Med 39:838–842CrossRefPubMed
22.
Zurück zum Zitat Nishinaka N, Tsutsui H, Yamaguchi K, Uehara T, Nagai S, Atsumi T (2014) Costal osteochondral autograft for reconstruction of advanced-stage osteochondritis dissecans of the capitellum. J Shoulder Elb Surg 23:1888–1897CrossRef Nishinaka N, Tsutsui H, Yamaguchi K, Uehara T, Nagai S, Atsumi T (2014) Costal osteochondral autograft for reconstruction of advanced-stage osteochondritis dissecans of the capitellum. J Shoulder Elb Surg 23:1888–1897CrossRef
23.
24.
Zurück zum Zitat Ovesen J, Olsen BS, Johannsen HV (2011) The clinical outcomes of mosaicplasty in the treatment of osteochondritis dissecans of the distal humeral capitellum of young athletes. J Shoulder Elb Surg 20:813–818CrossRef Ovesen J, Olsen BS, Johannsen HV (2011) The clinical outcomes of mosaicplasty in the treatment of osteochondritis dissecans of the distal humeral capitellum of young athletes. J Shoulder Elb Surg 20:813–818CrossRef
25.
Zurück zum Zitat Paul J, Sagstetter A, Kriner M, Imhoff AB, Spang J, Hinterwimmer S (2009) Donor-site morbidity after osteochondral autologous transplantation for lesions of the talus. J Bone Joint Surg Am 91:1683–1688CrossRefPubMed Paul J, Sagstetter A, Kriner M, Imhoff AB, Spang J, Hinterwimmer S (2009) Donor-site morbidity after osteochondral autologous transplantation for lesions of the talus. J Bone Joint Surg Am 91:1683–1688CrossRefPubMed
26.
Zurück zum Zitat Rahusen FT, Brinkman JM, Eygendaal D (2006) Results of arthroscopic debridement for osteochondritis dissecans of the elbow. Br J Sports Med 40:966–969CrossRefPubMedPubMedCentral Rahusen FT, Brinkman JM, Eygendaal D (2006) Results of arthroscopic debridement for osteochondritis dissecans of the elbow. Br J Sports Med 40:966–969CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Reddy S, Pedowitz DI, Parekh SG, Sennett BJ, Okereke E (2007) The morbidity associated with osteochondral harvest from asymptomatic knees for the treatment of osteochondral lesions of the talus. Am J Sports Med 35:80–85CrossRefPubMed Reddy S, Pedowitz DI, Parekh SG, Sennett BJ, Okereke E (2007) The morbidity associated with osteochondral harvest from asymptomatic knees for the treatment of osteochondral lesions of the talus. Am J Sports Med 35:80–85CrossRefPubMed
28.
Zurück zum Zitat Sato K, Nakamura T, Toyama Y, Ikegami H (2008) Costal osteochondral grafts for osteochondritis dissecans of the capitulum humeri. Tech Hand Up Extrem Surg 12:85–91CrossRefPubMed Sato K, Nakamura T, Toyama Y, Ikegami H (2008) Costal osteochondral grafts for osteochondritis dissecans of the capitulum humeri. Tech Hand Up Extrem Surg 12:85–91CrossRefPubMed
29.
Zurück zum Zitat Schoch B, Wolf BR (2010) Osteochondritis dissecans of the capitellum: minimum 1-year follow-up after arthroscopic debridement. Arthroscopy 26:1469–1473CrossRefPubMed Schoch B, Wolf BR (2010) Osteochondritis dissecans of the capitellum: minimum 1-year follow-up after arthroscopic debridement. Arthroscopy 26:1469–1473CrossRefPubMed
30.
Zurück zum Zitat Shimada K, Tanaka H, Matsumoto T, Miyake J, Higuchi H, Gamo K, Fuji T (2012) Cylindrical costal osteochondral autograft for reconstruction of large defects of the capitellum due to osteochondritis dissecans. J Bone Joint Surg Am 94:992–1002CrossRefPubMedPubMedCentral Shimada K, Tanaka H, Matsumoto T, Miyake J, Higuchi H, Gamo K, Fuji T (2012) Cylindrical costal osteochondral autograft for reconstruction of large defects of the capitellum due to osteochondritis dissecans. J Bone Joint Surg Am 94:992–1002CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Takeba J, Takahashi T, Watanabe S, Imai H, Kikuchi S, Umakoshi K, Matsumoto H, Ohshita M, Miura H, Aibiki M (2015) Short-term clinical results of arthroscopic osteochondral fixation for elbow osteochondritis dissecans in teenaged baseball players. J Shoulder Elb Surg 24:1749–1756CrossRef Takeba J, Takahashi T, Watanabe S, Imai H, Kikuchi S, Umakoshi K, Matsumoto H, Ohshita M, Miura H, Aibiki M (2015) Short-term clinical results of arthroscopic osteochondral fixation for elbow osteochondritis dissecans in teenaged baseball players. J Shoulder Elb Surg 24:1749–1756CrossRef
32.
Zurück zum Zitat van Bergen CJ, van den Ende KI, Ten Brinke B, Eygendaal D (2016) Osteochondritis dissecans of the capitellum in adolescents. World J Orthop 7:102–108CrossRefPubMedPubMedCentral van Bergen CJ, van den Ende KI, Ten Brinke B, Eygendaal D (2016) Osteochondritis dissecans of the capitellum in adolescents. World J Orthop 7:102–108CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Weigelt L, Siebenlist S, Hensler D, Imhoff AB, Vogt S (2015) Treatment of osteochondral lesions in the elbow: results after autologous osteochondral transplantation. Arch Orthop Trauma Surg 135:627–634CrossRefPubMed Weigelt L, Siebenlist S, Hensler D, Imhoff AB, Vogt S (2015) Treatment of osteochondral lesions in the elbow: results after autologous osteochondral transplantation. Arch Orthop Trauma Surg 135:627–634CrossRefPubMed
34.
Zurück zum Zitat Westermann RW, Hancock KJ, Buckwalter JA, Kopp B, Glass N, Wolf BR (2016) Return to sport after operative management of osteochondritis dissecans of the capitellum: a systematic review and meta-analysis. Orthop J Sports Med 4:2325967116654651CrossRefPubMedPubMedCentral Westermann RW, Hancock KJ, Buckwalter JA, Kopp B, Glass N, Wolf BR (2016) Return to sport after operative management of osteochondritis dissecans of the capitellum: a systematic review and meta-analysis. Orthop J Sports Med 4:2325967116654651CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Yamamoto Y, Ishibashi Y, Tsuda E, Sato H, Toh S (2006) Osteochondral autograft transplantation for osteochondritis dissecans of the elbow in juvenile baseball players: minimum 2-year follow-up. Am J Sports Med 34:714–720CrossRefPubMed Yamamoto Y, Ishibashi Y, Tsuda E, Sato H, Toh S (2006) Osteochondral autograft transplantation for osteochondritis dissecans of the elbow in juvenile baseball players: minimum 2-year follow-up. Am J Sports Med 34:714–720CrossRefPubMed
Metadaten
Titel
Donor-site morbidity after osteochondral autologous transplantation for osteochondritis dissecans of the capitellum: a systematic review and meta-analysis
verfasst von
Rens Bexkens
Paul T. Ogink
Job N. Doornberg
Gino M. M. J. Kerkhoffs
Denise Eygendaal
Luke S. Oh
Michel P. J. van den Bekerom
Publikationsdatum
08.04.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Knee Surgery, Sports Traumatology, Arthroscopy / Ausgabe 7/2017
Print ISSN: 0942-2056
Elektronische ISSN: 1433-7347
DOI
https://doi.org/10.1007/s00167-017-4516-8

Weitere Artikel der Ausgabe 7/2017

Knee Surgery, Sports Traumatology, Arthroscopy 7/2017 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.